Based on the Apyx Medical Inc stock forecast from 1 analysts, the average analyst target price for Apyx Medical Inc is USD 2.25 over the next 12 months. Apyx Medical Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Apyx Medical Inc is Very Bearish, which is based on 0 positive signals and 9 negative signals. At the last closing, Apyx Medical Inc’s stock price was USD 0.90. Apyx Medical Inc’s stock price has changed by -26.83% over the past week, -24.37% over the past month and -38.78% over the last year.
No recent analyst target price found for Apyx Medical Inc
No recent average analyst rating found for Apyx Medical Inc
Company Overview Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Read Less
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offer...Read More
Frequently Asked Questions About Apyx Medical Inc (APYX) Stock
Based on ratings from 1 analysts Apyx Medical Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Very Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on APYX's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for APYX is USD 2.25 over the next 12 months. The maximum analyst target price is USD 2.25 while the minimum anlayst target price is USD 2.25.
APYX stock's Price/Earning ratio is 4.30.
Our analysis grades APYX stock's Price / Earning ratio at D. This means that APYX stock's Price/Earning ratio is above 35% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this APYX may be fairly valued for its sector
The last closing price of APYX's stock was USD 0.90.
The most recent market capitalization for APYX is USD 0.04B.
Based on targets from 1 analysts, the average taret price for APYX is projected at USD 2.25 over the next 12 months.
This means that APYX's stock price may go up by +150.00% over the next 12 months.
We can't find any ETFs which contains Apyx Medical Inc's stock.
As per our most recent records Apyx Medical Inc has 252 Employees.
Apyx Medical Inc's registered address is 5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004.
You can get more information about it from Apyx Medical Inc's website at https://apyxmedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Apyx Medical Inc (APYX) Stock
Based on ratings from 1 analysts Apyx Medical Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Very Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on APYX's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for APYX is USD 2.25 over the next 12 months. The maximum analyst target price is USD 2.25 while the minimum anlayst target price is USD 2.25.
APYX stock's Price/Earning ratio is 4.30.
Our analysis grades APYX stock's Price / Earning ratio at D. This means that APYX stock's Price/Earning ratio is above 35% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this APYX may be fairly valued for its sector
The last closing price of APYX's stock was USD 0.90.
The most recent market capitalization for APYX is USD 0.04B.
Based on targets from 1 analysts, the average taret price for APYX is projected at USD 2.25 over the next 12 months.
This means that APYX's stock price may go up by +150.00% over the next 12 months.
We can't find any ETFs which contains Apyx Medical Inc's stock.
As per our most recent records Apyx Medical Inc has 252 Employees.
Apyx Medical Inc's registered address is 5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004.
You can get more information about it from Apyx Medical Inc's website at https://apyxmedical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for APYX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
